(Q39822565)

14 September 2017

title

Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis (English)

1 reference

14 September 2017

1 reference

1 reference

1 reference

Marie I

1

1 reference

14 September 2017

Jouen F

series ordinal

2

1 reference

14 September 2017

Hellot MF

series ordinal

3

1 reference

14 September 2017

Levesque H

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

19 November 2007

1 reference

British Journal of Dermatology

14 September 2017

published in

1 reference

14 September 2017

volume

158

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

141-144

1 reference

Vascular Disease in Progressive Systemic Sclerosis (Scleroderma)

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08309.X

More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08309.X

Systemic sclerosis. A vascular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08309.X

The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08309.X

Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08309.X

Antibodies to beta2 glycoprotein I and cardiolipin in SSc

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08309.X

Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08309.X

Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08309.X

Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08309.X

Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08309.X

10.1111/J.1365-2133.2007.08309.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference